| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 03/10/2005 | WO2005020882A2 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 03/10/2005 | US20050054683 Microbiocides; bacteriocides; oxazolidinone compound |
| 03/10/2005 | US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | CA2824106A1 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 03/10/2005 | CA2537093A1 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 03/09/2005 | EP1511704A1 Polymerisation inhibitor |
| 03/09/2005 | CN1192019C Cyclic amine derivatives |
| 03/08/2005 | US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants. |
| 03/03/2005 | WO2005019177A1 Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof |
| 03/03/2005 | WO2004103309A3 Immunosuppressant compounds and compositions |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1191372C Resolution of trans-2-(alkoxycarbonylethyl)-laitams useful in synthesis of 1-(4-fluorphenyl)-3(R)-[3(S)-hydroxy-3-(flurophenyl)-propyl)]-4(S)-(4-hydroxyphenyl)-2-azetidinone |
| 02/24/2005 | WO2005016883A2 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
| 02/24/2005 | WO2004096235A8 Anti-cancer phosphonate analogs |
| 02/24/2005 | WO2004014960A3 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography |
| 02/24/2005 | US20050043547 Process for producing optically active azetidine-2-carboxylic acids |
| 02/24/2005 | US20050043392 Moderators of mnocyte chemoattractant protein; therapy for asthma; multiple sclerosis, antiarthritic agents, atherosclerosis |
| 02/23/2005 | CN1585747A Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 |
| 02/22/2005 | US6858727 Intermediate of carbapenem antibiotics and process for the preparation thereof |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 02/16/2005 | CN1582168A Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 02/16/2005 | CN1189476C New thrombin inhibitors, their preparation and use |
| 02/10/2005 | WO2005012244A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/10/2005 | US20050033055 Edg receptor agonists |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | CA2534473A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/08/2005 | US6852865 Epoxides, aziridines, thiiranes, oxetanes, lactones, lactams and analogous compounds are reacted with carbon monoxide in the presence of a catalytically effective amount of catalyst complex of transition metal carbonyl and Lewis acid |
| 02/03/2005 | WO2005009955A1 Ezetimibe polymorphs |
| 02/03/2005 | DE10335092B3 Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung Benzoylureido substituted-o-benzoylamide, processes for their preparation and their use |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575169A Mch antagonists for the treatment of obesity |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 01/27/2005 | US20050020563 Nover diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use |
| 01/26/2005 | CN1569830A Preparation method of (S)-beta-azetidinone-4-benzyl carboxylate |
| 01/25/2005 | US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis |
| 01/20/2005 | WO2005005446A1 Processes for producing carbapenem intermediate |
| 01/20/2005 | WO2004069793A3 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 01/20/2005 | US20050014724 Immunosuppressant compounds and compositions |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/18/2005 | CA2158458C Taxanes prepared by beta-lactams and ammonium alkoxides |
| 01/13/2005 | WO2004103966B1 Chiral 2-azetidinone compounds, process and use thereof |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | WO2004087650A3 Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors |
| 01/13/2005 | US20050009786 Immunosuppressant compounds and compositions |
| 01/12/2005 | EP1253140B1 Process for cyclizing optically active 4-amino-2-halogenobutyric acids |
| 01/12/2005 | CN1564695A Pharmaceutical formulation |
| 01/11/2005 | US6841667 Nucleophilic kinetic resolution of cyclic substrates using silyl azides |
| 01/06/2005 | WO2005000809A1 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 01/06/2005 | US20050004164 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
| 01/05/2005 | CN1183110C Process for production of N-protected azetidinie-2-carboxylic acids (AzeOHs) |
| 01/04/2005 | US6838567 Process for producing optically active azetidine-2-carboxylic acids |
| 01/04/2005 | US6838478 Use as anticoagulants; competitive inhibitors of thrombin; for example, 1-(phenyl-2-hydroxyethane-1,1-diylcarbonyl), 2-((4-amidinophenyl)-alkylaminocarbonyl)azetidine |
| 12/30/2004 | US20040267008 Cyclization of (2-Oxo-4-(2-oxo-2-(tetrahydrofuran-2-yl)-ethylsulfanyl)-3-phenylacetylamino -azetidin-1-yl)-(trimethyl- alpha -phosphanylidene)-acetic acid 4-nitro-benzyl ester; reacting with acid |
| 12/29/2004 | WO2004113297A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2004 | EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators |
| 12/29/2004 | CN1182112C Process for the production of a N-benzyl azetidine-2-carboxylic acid ester |
| 12/28/2004 | US6835727 Bone disorders; osteoporosis; rheumatic diseases |
| 12/23/2004 | WO2004099150A3 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/23/2004 | WO2004072025A3 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 12/22/2004 | EP1487435A1 Azetidine derivatives as ccr-3 receptor antagonists |
| 12/22/2004 | CN1556700A Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
| 12/16/2004 | WO2002076177A3 Design and synthesis of optimized ligands for ppar |
| 12/16/2004 | US20040254369 3(S)-(4-hydroxyphenyl)-3-methanesulfonyloxy-propionic acid methyl ester; intermediate to azetidinone compounds; hypocholesterolemic agents |
| 12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
| 12/14/2004 | US6831078 3-aryl substituted having halo or alkylhalo groups; anxiety, epilepsy; presurgery muscle relaxant |
| 12/09/2004 | US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents |
| 12/09/2004 | DE10322191A1 N-sulfonylierte Aminosäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung N-sulfonylated amino acid derivatives, processes for their preparation and their use |
| 12/09/2004 | CA2526530A1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
| 12/08/2004 | EP1483241A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 12/08/2004 | EP1483228A1 Nk1 antagonists |
| 12/08/2004 | CN1553892A Novel compounds and compositions as cathepsin inhibitors |
| 12/08/2004 | CN1178911C Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders |
| 12/08/2004 | CN1178905C Novel peptide derivative |
| 12/08/2004 | CN1178901C New-cyclic alpha-amino-gamma hydroxy amide compound and its preparing method and medicinal composition containing said compound |
| 12/07/2004 | CA2156734C Ozonide reducing agent |
| 12/02/2004 | WO2004103966A1 Chiral 2-azetidinone compounds, process and use thereof |
| 12/02/2004 | WO2004103309A2 Immunosuppressant compounds and compositions |
| 12/02/2004 | US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
| 12/02/2004 | US20040242492 Mandelic acid derivatives and their use as thrombin inhibitors |
| 12/01/2004 | EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds |
| 11/25/2004 | WO2004101507A2 N-sulphonylated amino acid derivatives and use thereof as matriptase inhibitors |
| 11/25/2004 | WO2004100960A2 Anti-inflammatory phosphonate compounds |
| 11/25/2004 | WO2004100888A2 N-thiolated azetidinones and anti-cancer use thereof |
| 11/25/2004 | US20040235911 hydroxyamidines; antibiotic resistance |
| 11/25/2004 | US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis |
| 11/25/2004 | US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease |
| 11/25/2004 | US20040235727 Comprising H 376/95, sodium dodecyl sulphate, and a polymer selected from hydroxypropyl methylcellulose, hydroxyethyl cellulose, and polyoxyethylene oxide; use in treatment of thromboembolism |
| 11/25/2004 | CA2525886A1 N-sulphonylated amino acid derivatives and their use as matriptase inhibitors |
| 11/24/2004 | EP1479666A1 Ester compound and medicinal use thereof |
| 11/24/2004 | CN1549808A New mandelic acid derivatives and their use as thrombin inhibitors |
| 11/23/2004 | US6822057 Olefin polymerization catalysts derived from Group-15 cationic compounds and processes using them |
| 11/18/2004 | WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 11/18/2004 | WO2004099134A2 Glutaminyl based dp iv-inhibitors |
| 11/18/2004 | WO2004099133A1 2”-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food |
| 11/18/2004 | WO2004099132A2 Process for the preparation of trans-isomers of diphenylazetidinone derivatives |